drugset
drugset / Trial / NCT04865445

Drug-drug Interaction Study of Midazolam and AT-527 (R07496998)

NCT04865445 ↗

Phase 1 Completed 24 enrolled Atea Pharmaceuticals, Inc. Hoffmann-La Roche · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Drug-drug interaction study of midazolam and AT-527 (R07496998)

Timeline

Start
2021-04-22
Primary completion
2021-05-15
Completion
2021-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject AT-527 Other / unclassified 550 mg —
Subject Midazolam Small molecule 2 mg —

Indications

No indication recorded.